Cargando…

Race is a risk factor for calcinosis in patients with JDM – early results from the CARRAnet registry study

Detalles Bibliográficos
Autores principales:	Hoeltzel, Mark F, Becker, Mara L, Robinson, Angela B, Feldman, Brian M, Huber, Adam, Reed, Ann M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403006/ http://dx.doi.org/10.1186/1546-0096-10-S1-A65

Ejemplares similares

Clinical characteristics of children with juvenile dermatomyositis recruited within the first 7 months of the CARRAnet registry
por: Hoeltzel, Mark F, et al.
Publicado: (2012)

Diagnostic evaluation and medication usage in a cohort of subjects with juvenile dermatomyositis from the CARRAnet registry
por: Robinson, Angela B, et al.
Publicado: (2012)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
por: Clara, Malagón, et al.
Publicado: (2011)

Description of the localized scleroderma subgroup of CARRAnet
por: Wu, Eveline, et al.
Publicado: (2012)

Proposal for the development of an international minimal data collection for juvenile dermatomyositis (JDM)
por: McCann, Liza J, et al.
Publicado: (2011)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

Use of immunosuppressive medications and prevalence of disability among patients with pediatric systemic lupus erythematosus: initial analysis of the CARRAnet registry
por: Hersh, Aimee, et al.
Publicado: (2012)

Disease characteristics and medication use in a multicenter cohort of children with juvenile idiopathic arthritis (JIA): preliminary analyses from the CARRAnet registry
por: Ringold, Sarah, et al.
Publicado: (2012)

Sleep, fatigue and quality of life in juvenile idiopathic arthritis (JIA) and Juvenile Dermatomyositis (JDM)
por: Avie, Y Butbul, et al.
Publicado: (2008)

What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era
por: Smith, S, et al.
Publicado: (2008)

Case of juvenile dermatomyositis (JDM), thrombotic thrombocytopenic purpura (TTP), and Purtscher retinopathy
por: Goldzweig, Ofra, et al.
Publicado: (2012)

Informatics methodology for the rapid, validated development of clinical research forms in CARRAnet: incorporating user-centered design into the Delphi technique
por: Inman, CJ, et al.
Publicado: (2012)

JDM update September 2014
por: Pilkington, Clarissa
Publicado: (2014)

Idiopathic calcinosis cutis universalis
por: Akura, Bina, et al.
Publicado: (2015)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008)

How do tissue infiltrating B cells and plasma cells correlate with other inflammatory features in muscle tissue from patients with JDM?
por: Sag, Erdal, et al.
Publicado: (2014)

Comparison of idiopathic and secondary uveitis patients seen in a dual pediatric rheumatology-ophthalmology clinic
por: Rizk, Victoria TE, et al.
Publicado: (2012)

Intracellular folate concentrations in Down syndrome patients with arthritis
por: Becker, Mara L, et al.
Publicado: (2012)

Currently recommended skin scores correlate highly in the assessment of patients with Juvenile Dermatomyositis (JDM)
por: Gebreamlak, Alexander, et al.
Publicado: (2023)

PReS-FINAL-2013: Sodium thiosulfate for the treatment of Juvenile Dermatomyositis complicated by calcinosis
por: Pagnini, I, et al.
Publicado: (2013)

Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate
por: Ursu, S, et al.
Publicado: (2011)

P11 An unusual case of Systemic Sclerosis/JDM overlap in a child with PAX8-related congenital hypothyroidism
por: Smith, Rachel, et al.
Publicado: (2022)

PReS-FINAL-2014: Excellent results of the conventional treatment in a child with late-diagnosed juvenile dermatomyositis with severe calcinosis
por: Nikishina, IP, et al.
Publicado: (2013)

Calcinosis and lipodystrophy: clinical presentation of 10 years non-treated juvenile dermatomyositis – case report
por: Velma, Selmanovic-Mulaosmanovic, et al.
Publicado: (2011)

Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use
por: McCann, Liza J., et al.
Publicado: (2015)

Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA)
por: Orandi, A. B., et al.
Publicado: (2017)

8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients
por: Ferrari, C, et al.
Publicado: (2008)

OA05 Clinical presentation, risk factors and prognosis of MDA5-positive JDM; clinical diversity and red flags
por: McLellan, Kirsty, et al.
Publicado: (2022)

Esophageal Mucosal Calcinosis: A Rare Site of Gastrointestinal Mucosal Calcinosis
por: Huber, Aaron R., et al.
Publicado: (2018)

PReS-FINAL-2275: Improvement of calcinosis cutis with intravenous pamidronate in a 2-year-old girl with progressive widespread skin calcification of unknown origin
por: Mrusek, S, et al.
Publicado: (2013)

Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM)
por: Abdul-Aziz, Rabheh, et al.
Publicado: (2017)

Therapy of autoinflammatory diseases: results from an international registry
por: ter Haar, NM, et al.
Publicado: (2011)

Spanish trauma icu registry (RETRAUCI). final results of the pilot phase
por: Chico-Fernández, M, et al.
Publicado: (2015)

The Eurofever Registry for autoinflammatory diseases: results of the first 15 months of enrolment
por: Toplak, N, et al.
Publicado: (2011)

Caffeine influence on the performance of the 5000m race
por: Marangon, Antonio FC, et al.
Publicado: (2011)

46 Universal calcinosis in juvenile dermatomyositis: a case report
por: Bahaz, N, et al.
Publicado: (2022)

Severe sepsis and drotrecogin alfa (activated) use: results from the PROGRESS registry
por: Beale, R, et al.
Publicado: (2007)

Elderly-onset calcinosis of hyperphosphataemic familial tumoural calcinosis/hyperostosis-hyperphosphataemia syndrome: the role of comorbid scleroderma
por: Iwasaki, Hiroaki
Publicado: (2023)

JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
por: Ll Wilkinson, Meredyth G., et al.
Publicado: (2021)

Cardiac MRI characteristics in patients with borderline pulmonary hypertension: results from the ASPIRE registry
por: Walker, Henry, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_om23gl8k787tln6p7kd95dmo36